Context Therapeutics Inc. 8-K Report: Key Insights from December 23, 2024

Here are the key insights extracted from the provided section of the financial report:

1. Entity Information:

• Company Name: Context Therapeutics Inc.
• CIK (Central Index Key): 0001842952
• State of Incorporation: Delaware (DE)
• SEC File Number: 001-40654
• EIN (Employer Identification Number): 86-3738787

2. Contact Information:

• Address: 2001 Market Street, Suite 3915 Unit #15, Philadelphia, PA 19103
• Phone Number: (267) 225-7416

3. Filing Information:

• Filing Type: 8-K (a report of unscheduled material events or corporate changes)
• Filing Date: December 23, 2024

4. Stock Information:

• Common Stock Ticker Symbol: CNTX
• Exchange: NASDAQ

5. Reporting Context:

• Reporting Period: The report covers a single day, December 23, 2024.

This information indicates that Context Therapeutics Inc. is a publicly traded company listed on NASDAQ, and the filing is an 8-K which typically provides important updates to shareholders.